Invention Grant
- Patent Title: Antiviral drug for severe fever with thrombocytopenia syndrome
-
Application No.: US16479081Application Date: 2018-01-16
-
Publication No.: US11001557B2Publication Date: 2021-05-11
- Inventor: Masanori Baba , Masaaki Toyama , Norikazu Sakakibara
- Applicant: Kagoshima University , Nobelpharma Co., Ltd.
- Applicant Address: JP Kagoshima; JP Tokyo
- Assignee: Kagoshima University,Nobelpharma Co., Ltd.
- Current Assignee: Kagoshima University,Nobelpharma Co., Ltd.
- Current Assignee Address: JP Kagoshima; JP Tokyo
- Agency: Lucas & Mercanti, LLP
- Priority: JPJP2017-007507 20170119
- International Application: PCT/JP2018/000887 WO 20180116
- International Announcement: WO2018/135449 WO 20180726
- Main IPC: C07D215/44
- IPC: C07D215/44 ; A61P31/12 ; C07D401/12 ; C07D413/12 ; C07D417/12

Abstract:
The present invention pertains to an antiviral drug for severe fever with thrombocytopenia syndrome, which contains a compound represented by formula (I) or a salt thereof, or a solvate of the compound or salt (In the formula, R1 and R2 are the same or different from each other, and each represents a substituted or unsubstituted C1-10 alkyl group, R1 and R2 may form a substituted or unsubstituted 5- or 6-member ring in conjunction with an adjacent nitrogen atom, and X represent a halogen atom.)
Public/Granted literature
- US20190389803A1 ANTIVIRAL DRUG FOR SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME Public/Granted day:2019-12-26
Information query